RADY CHILDRENS HOSPITAL - SAN DIEGO
- Type
- Teaching hospital
- Where
- San Diego, CA
- Medicare CCN
- 053303
- Received
- $6,122,581 in 63 records, 2025 ($5,678,105 general, $444,475 research)
- Source
- CMS Open Payments search ↗
On this site
- Nonprofit contractor: RADY CHILDRENS HOSPITAL SAN DIEGO Fuzzy (name and state)
- Nonprofit: RADY CHILDRENS HOSPITAL SAN DIEGO Fuzzy (name and state)
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2025 | General payment | 38 | $5,678,105 |
| 2025 | Research payment | 25 | $444,475 |
By company
| Company | Records | Amount | Years |
|---|---|---|---|
| Alexion Pharmaceuticals, Inc. | 3 | $5,510,000 | 2025 |
| Ionis Pharmaceuticals, Inc. | 13 | $208,301 | 2025 |
| E.R. Squibb & Sons, L.L.C. | 2 | $140,572 | 2025 |
| ABBVIE INC. | 5 | $79,922 | 2025 |
| Siemens Medical Solutions USA, Inc. | 3 | $42,500 | 2025 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $38,327 | 2025 |
| OrthoPediatrics Corp. | 1 | $24,700 | 2025 |
| Stryker Corporation | 9 | $13,074 | 2025 |
| National Marrow Donor Program | 5 | $9,980 | 2025 |
| MED-EL Corporation | 1 | $9,090 | 2025 |
| Celgene Corporation | 1 | $8,000 | 2025 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $7,825 | 2025 |
| PFIZER INC. | 2 | $6,800 | 2025 |
| KLS-Martin L.P. | 5 | $5,158 | 2025 |
| KARL STORZ Endoscopy-America | 2 | $5,000 | 2025 |
| Edwards Lifesciences Corporation | 1 | $5,000 | 2025 |
| Olympus Corporation of the Americas | 1 | $4,000 | 2025 |
| Abbott Laboratories | 1 | $2,500 | 2025 |
| Insulet Corporation | 2 | $1,000 | 2025 |
| Advanced Bionics, LLC | 1 | $500 | 2025 |
| Novartis Pharmaceuticals Corporation | 1 | $229 | 2025 |
| Boston Scientific Corporation | 1 | $100 | 2025 |
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a v | 8 | $5,544,482 |
| Research payment | 25 | $444,475 |
| Grant | 7 | $55,000 |
| Long term medical supply or device loan | 13 | $25,453 |
| Consulting Fee | 1 | $24,700 |
| Space rental or facility fees (teaching hospital only) | 5 | $24,000 |
| Charitable Contribution | 2 | $2,600 |
| Debt forgiveness | 2 | $1,870 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2025-12-31 | Stryker Corporation | $3,394 | Long term medical supply or device loan | In-kind items and services | PRIME SERIES Device, PATIENT HANDLING - PH | 2025 | |
| 2025-12-31 | Stryker Corporation | $3,394 | Long term medical supply or device loan | In-kind items and services | PRIME SERIES Device, PATIENT HANDLING - PH | 2025 | |
| 2025-12-31 | Stryker Corporation | $3,394 | Long term medical supply or device loan | In-kind items and services | PRIME SERIES Device, PATIENT HANDLING - PH | 2025 | |
| 2025-12-31 | Stryker Corporation | $1,763 | Debt forgiveness | Cash or cash equivalent | 2025 | ||
| 2025-12-31 | Stryker Corporation | $461 | Long term medical supply or device loan | In-kind items and services | ISOFLEX LAL Device, PATIENT CARE - PC | 2025 | |
| 2025-12-31 | Stryker Corporation | $461 | Long term medical supply or device loan | In-kind items and services | ISOFLEX LAL Device, PATIENT CARE - PC | 2025 | |
| 2025-12-31 | Stryker Corporation | $106 | Debt forgiveness | Cash or cash equivalent | 2025 | ||
| 2025-12-31 | Stryker Corporation | $50 | Long term medical supply or device loan | In-kind items and services | ISOFLEX LAL Device, PATIENT CARE - PC | 2025 | |
| 2025-12-31 | Stryker Corporation | $47 | Long term medical supply or device loan | In-kind items and services | PROCUITY Device, PATIENT HANDLING - PH | 2025 | |
| 2025-12-30 | Ionis Pharmaceuticals, Inc. | $7,900 | Research payment | Cash or cash equivalent | ION440-CS1 | 2025 | |
| 2025-12-30 | Ionis Pharmaceuticals, Inc. | $6,881 | Research payment | Cash or cash equivalent | ION440-CS1 | 2025 | |
| 2025-12-26 | KLS-Martin L.P. | $1,973 | Long term medical supply or device loan | Cash or cash equivalent | DISTRACTION, INTERNAL,EXTENSION, CARDANIC, FOR ACT ARM,16 MM,TI-6AL-4V,QTY:001 EA Device, Osteosynthesis | 2025 | |
| 2025-12-26 | KLS-Martin L.P. | $1,920 | Long term medical supply or device loan | Cash or cash equivalent | DISTRACTION, INTERNAL,ACT ARM, DIRECT DRIVE,7 MM,TI-6AL-4V,QTY:001 EA Device, Osteosynthesis | 2025 | |
| 2025-12-26 | KLS-Martin L.P. | $788 | Long term medical supply or device loan | Cash or cash equivalent | DISTRACTION, INTERNAL,PATIENT SCREWDRIVER, HEX, ZURICH, 1.0 MM PER TURN, GOLD,2.5 MM HEX,QTY:001 EA Device, Osteosynthesis | 2025 | |
| 2025-12-26 | Insulet Corporation | $500 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | OMNIPOD Device, Insulin Pump | 2025 | |
| 2025-12-26 | KLS-Martin L.P. | $431 | Long term medical supply or device loan | Cash or cash equivalent | DISTRACTION, INTERNAL,PATIENT SCREWDRIVER, HEX, 0.5 MM PER TURN, PURPLE,2.5 MM HEX,QTY:001 EA Device, Osteosynthesis | 2025 | |
| 2025-12-26 | KLS-Martin L.P. | $44 | Long term medical supply or device loan | Cash or cash equivalent | LEVEL ONE CMF,SCREW, MAXDRIVE,1.5 X 5 MM,TI-6AL-4V,QTY:001 EA Device, Osteosynthesis | 2025 | |
| 2025-12-22 | Celgene Corporation | $8,000 | Grant | Cash or cash equivalent | 2025 | ||
| 2025-12-16 | Boston Scientific Corporation | $100 | Charitable Contribution | Cash or cash equivalent | 2025 | ||
| 2025-11-28 | Ionis Pharmaceuticals, Inc. | $24,757 | Research payment | Cash or cash equivalent | ION440-CS1 | 2025 | |
| 2025-11-28 | Ionis Pharmaceuticals, Inc. | $897 | Research payment | Cash or cash equivalent | ION440-CS1 | 2025 | |
| 2025-11-14 | Siemens Medical Solutions USA, Inc. | $5,000 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2025 | ||
| 2025-10-30 | Ionis Pharmaceuticals, Inc. | $11,801 | Research payment | Cash or cash equivalent | ION440-CS1 | 2025 | |
| 2025-10-28 | KARL STORZ Endoscopy-America | $2,500 | Grant | Cash or cash equivalent | 2025 | ||
| 2025-10-28 | KARL STORZ Endoscopy-America | $2,500 | Grant | Cash or cash equivalent | 2025 | ||
| 2025-10-17 | National Marrow Donor Program | $3,050 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2025 | ||
| 2025-09-30 | Ionis Pharmaceuticals, Inc. | $12,222 | Research payment | Cash or cash equivalent | ION440-CS1 | 2025 | |
| 2025-09-30 | Ionis Pharmaceuticals, Inc. | $2,872 | Research payment | Cash or cash equivalent | ION440-CS1 | 2025 | |
| 2025-09-24 | Edwards Lifesciences Corporation | $5,000 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | 2025 | ||
| 2025-09-15 | ABBVIE INC. | $1,665 | Research payment | In-kind items and services | VENCLEXTA Drug, ONCOLOGY | Pilot Study of Venetoclax in Combination with Conventional Chemotherapy in Pediatric Patients with Acute Myeloid Leukemi | 2025 |
| 2025-09-10 | Olympus Corporation of the Americas | $4,000 | Grant | In-kind items and services | EVIS EXERA III DUODENOVIDEOSCOPE Device, Gastroenterology | 2025 | |
| 2025-08-28 | Ionis Pharmaceuticals, Inc. | $37,664 | Research payment | Cash or cash equivalent | ION440-CS1 | 2025 | |
| 2025-08-28 | Ionis Pharmaceuticals, Inc. | $7,650 | Research payment | Cash or cash equivalent | ION440-CS1 | 2025 | |
| 2025-08-28 | Ionis Pharmaceuticals, Inc. | $6,952 | Research payment | Cash or cash equivalent | ION440-CS1 | 2025 | |
| 2025-08-28 | Ionis Pharmaceuticals, Inc. | $1,077 | Research payment | Cash or cash equivalent | ION440-CS1 | 2025 | |
| 2025-08-20 | Takeda Pharmaceuticals U.S.A., Inc. | $35,327 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2025 | ||
| 2025-08-06 | Siemens Medical Solutions USA, Inc. | $35,000 | Grant | Cash or cash equivalent | 2025 | ||
| 2025-07-31 | MED-EL Corporation | $9,090 | Long term medical supply or device loan | In-kind items and services | Mi1250 SYNCHRONY 2 FLEXsoft Device, Cochlear Implant | 2025 | |
| 2025-07-30 | Ionis Pharmaceuticals, Inc. | $43,811 | Research payment | Cash or cash equivalent | ION440-CS1 | 2025 | |
| 2025-07-30 | Ionis Pharmaceuticals, Inc. | $43,811 | Research payment | Cash or cash equivalent | ION440-CS1 | 2025 | |
| 2025-07-29 | ABBVIE INC. | $13,018 | Research payment | In-kind items and services | VENCLEXTA Drug, ONCOLOGY | Pilot Study of Venetoclax in Combination with Conventional Chemotherapy in Pediatric Patients with Acute Myeloid Leukemi | 2025 |
| 2025-07-23 | National Marrow Donor Program | $1,565 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2025 | ||
| 2025-07-16 | E.R. Squibb & Sons, L.L.C. | $139,002 | Research payment | Cash or cash equivalent | CAMZYOS Drug, Cardiovascular | A Randomized, Double-blind, Placebo-controlled Clinical Study to Evaluate Mavacamten in Adolescents (age 12 years to < 1 | 2025 |
| 2025-07-15 | Advanced Bionics, LLC | $500 | Grant | Cash or cash equivalent | HIRES ULTRA CI HIFOCUS MS ELECTRODE Device, OTOLARYNGOLOGY | 2025 | |
| 2025-06-23 | ABBVIE INC. | $65,090 | Research payment | In-kind items and services | VENCLEXTA Drug, ONCOLOGY | A23-488;Venclexta;Blister Card: ABT-199 50mg Film-coated Tablet 1x8, 8 Tablets | 2025 |
| 2025-06-23 | ABBVIE INC. | $85 | Research payment | In-kind items and services | VENCLEXTA Drug, ONCOLOGY | A23-488;Venclexta;Carton: Venetoclax (ABT-199) 10mg Powder for Oral Suspension Sachet 4 Sachets | 2025 |
| 2025-06-23 | ABBVIE INC. | $62 | Research payment | In-kind items and services | VENCLEXTA Drug, ONCOLOGY | A23-488;Venclexta;Carton: Venetoclax (ABT-199) 25mg Powder for Oral Suspension Sachet 4 Sachets | 2025 |
| 2025-06-20 | PFIZER INC. | $5,200 | Research payment | Cash or cash equivalent | THE UNITED STATES PEDIATRIC MULTICENTER PNEUMOCOCCAL SURVEILLANCEWI227301 | 2025 | |
| 2025-06-20 | PFIZER INC. | $1,600 | Research payment | Cash or cash equivalent | THE UNITED STATES PEDIATRIC MULTICENTER PNEUMOCOCCAL SURVEILLANCEWI227301 | 2025 | |
| 2025-06-18 | Alexion Pharmaceuticals, Inc. | $15,000 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | 2025 | ||
| 2025-06-17 | Siemens Medical Solutions USA, Inc. | $2,500 | Grant | Cash or cash equivalent | 2025 | ||
| 2025-06-04 | Alexion Pharmaceuticals, Inc. | $5,000,000 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2025 | ||
| 2025-05-02 | National Marrow Donor Program | $825 | Research payment | Cash or cash equivalent | 1/2A Phase III Randomized Trial Comparing Unrelated Donor Bone Marrow Transplantation with Immune Suppressive Therapy fo | 2025 | |
| 2025-04-25 | National Marrow Donor Program | $1,570 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2025 | ||
| 2025-04-16 | Alexion Pharmaceuticals, Inc. | $495,000 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2025 | ||
| 2025-04-02 | Insulet Corporation | $500 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | OMNIPOD Device, Insulin Pump | 2025 | |
| 2025-03-19 | Takeda Pharmaceuticals U.S.A., Inc. | $3,000 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | 2025 | ||
| 2025-03-05 | OrthoPediatrics Corp. | $24,700 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-03-03 | Abbott Laboratories | $2,500 | Charitable Contribution | Cash or cash equivalent | XIENCE V Device, Structural Heart | 2025 | |
| 2025-02-25 | E.R. Squibb & Sons, L.L.C. | $1,570 | Research payment | Cash or cash equivalent | CAMZYOS Drug, Cardiovascular | A Randomized, Double-blind, Placebo-controlled Clinical Study to Evaluate Mavacamten in Adolescents (age 12 years to < 1 | 2025 |
| 2025-01-24 | National Marrow Donor Program | $2,970 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2025 | ||
| 2025-01-15 | Novartis Pharmaceuticals Corporation | $229 | Research payment | In-kind items and services | KYMRIAH Drug, Oncology | A single arm phase II trial in first line high risk HR pediatric and young adult patients with Bcell acute lymphoblastic | 2025 |
| 2025-01-13 | Boehringer Ingelheim Pharmaceuticals, Inc. | $7,825 | Research payment | Cash or cash equivalent | PRADAXA Drug, CARDIOVASCULAR | US observational study of DE oral pellets in patients <12 y | 2025 |
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In San Diego, CA, county San Diego County, CA, state California; placed by its city name.
| Measure | Place (city or town) San Diego, CA | County San Diego County, CA | State California |
|---|---|---|---|
| Population B01003 | 1,389,526 | 3,288,774 | 39,287,377 |
| Population, 2020 census P1 | 1,386,932 | 3,298,634 | 39,538,223 |
| Median age B01002 | 36.2 | 37.3 | 37.9 |
| Under 18 B01001 | 18.4% | 20.9% | 22.0% |
| 65 and over B01001 | 14.6% | 15.4% | 15.7% |
| Households B11001 | 530,412 | 1,171,278 | 13,548,091 |
| Foreign born B05002 | 25.1% | 22.8% | 27.0% |
| Median household income B19013 | $108,077 | $106,268 | $99,122 |
| Median family income B19113 | $128,006 | $122,377 | $113,346 |
| Per capita income B19301 | $57,083 | $51,976 | $49,513 |
| Poverty rate B17001 | 11.0% | 10.3% | 12.0% |
| Unemployment rate B23025 | 6.0% | 6.1% | 6.6% |
| Civilian labor force B23025 | 755,893 | 1,689,384 | 20,068,466 |
| Mean commute (minutes) B08013 | 23.5 | 25.5 | 28.7 |
| Bachelor's degree or higher B15003 | 51.0% | 43.2% | 37.1% |
| Housing units B25001 | 568,668 | 1,250,641 | 14,644,735 |
| Owner-occupied B25003 | 47.3% | 54.6% | 55.9% |
| Renters B25003 | 52.7% | 45.4% | 44.1% |
| Median home value B25077 | $906,700 | $854,700 | $734,700 |
| Median gross rent B25064 | $2,313 | $2,246 | $2,036 |
| White, not Hispanic B03002 | 40.9% | 42.4% | 33.8% |
| Black B03002 | 5.3% | 4.4% | 5.2% |
| Hispanic or Latino B03002 | 29.8% | 34.6% | 40.2% |
| Asian B03002 | 17.3% | 12.1% | 15.3% |
| American Indian and Alaska Native B03002 | 0.2% | 0.2% | 0.3% |
Economy now FRED unemployment 5.1% in Sep 2026 (5.5% a year earlier); per capita personal income $90,957 in 2025, up 30% in five years (+4.3% after inflation); the state; Source: FRED, Federal Reserve Bank of St. Louis.
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in San Diego, CA.
Comments